(January 17, 2012) -- The FTC has cleared Gilead Sciences’s $11 billion acquisition of a rival firm, Pharmasset, after Gilead withdrew and refiled its Hart-Scott-Rodino forms in late December. Gilead said it submitted the forms on December 13, but “voluntarily withdrew and re-filed these forms” on December 27....